XNASATPC
Market cap5mUSD
Dec 20, Last price
1.45USD
1D
21.85%
1Q
-24.48%
IPO
-98.79%
Name
Agape ATP Corp
Chart & Performance
P/E
—
P/S
4.04
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-27.41%
Rev. gr., 5y
-1.53%
Revenues
1m
-22.92%
Net income
-2m
L+24.61%
CFO
-2m
L+146.63%
Earnings
Mar 31, 2025
Profile
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company offers three series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE names. Its products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP2 Energized Mineral Concentrate, a nutritional supplement, which supports and enhances nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1 Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. The company also provides BEAUNIQUE Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and ORYC-Organic Youth Care Cleansing Bar, an organic cleansing soap for the skin. In addition, it offers N°1 Med-Hydration, a mask that enhances skin moisture and luminosity; N°2 Med-Whitening, a mask for boosting skin moisture level and protecting skin against UV radiation; N°3 Med-Firming, which provides protection and maintenance of the basal skin collagen production; ÉNERGÉTIQUE hyaluronic acid serum; and ÉNERGÉTIQUE mousse facial cleanser, as well as Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. The company was incorporated in 2016 and is based in Kuala Lumpur, Malaysia.
IPO date
Sep 17, 2018
Employees
30
Domiciled in
MY
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | 1,431 -22.92% | 1,857 82.56% | 1,017 -70.55% | ||||||
Cost of revenue | 3,578 | 3,390 | 2,754 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (2,147) | (1,533) | (1,737) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | 4 | (4) | 137 | ||||||
Tax Rate | |||||||||
NOPAT | (2,150) | (1,529) | (1,874) | ||||||
Net income | (2,102) 24.61% | (1,687) -33.17% | (2,524) -811.52% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 5,408 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 146 | 83 | 157 | ||||||
Long-term debt | 730 | 83 | 324 | ||||||
Deferred revenue | (16) | ||||||||
Other long-term liabilities | 16 | ||||||||
Net debt | (3,977) | (1,290) | (2,207) | ||||||
| Cash flow | |||||||||
Cash from operating activities | (2,002) | (812) | (846) | ||||||
CAPEX | (52) | (32) | (4) | ||||||
Cash from investing activities | (17) | (32) | (4) | ||||||
Cash from financing activities | 5,398 | (234) | (19) | ||||||
FCF | (2,448) | (1,140) | (511) | ||||||
| Balance | |||||||||
Cash | 4,832 | 1,438 | 2,598 | ||||||
Long term investments | 20 | 17 | 91 | ||||||
Excess cash | 4,781 | 1,362 | 2,638 | ||||||
Stockholders' equity | (6,998) | (4,908) | (3,137) | ||||||
Invested Capital | 11,816 | 6,467 | 6,686 | ||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 75,815 | 87,822 | 376,216 | ||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (1,923) | (1,315) | (1,520) | ||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||